Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/8/2020
SIETES contiene 93082 citas

 
 
 1 a 18 de 18 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L, ARISTOTLE Committees and Investigators. Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol 2018;71:13 de marzo. [Ref.ID 102547]
2.Tiene citas relacionadas Cita con resumen
Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, ten Berg JM, Steg PG, Hohnloser SH, for the RE-DUAL PCI Steering Committee and Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2017;377:1513-24. [Ref.ID 102099]
3. Cita con resumen
Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature . Eur Heart J 2015;36:1831-8. [Ref.ID 99037]
4.Enlace a cita original Cita con resumen
Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensy G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study. Circulation 2013;128:237-43. [Ref.ID 95955]
5.Tiene citas relacionadas
Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Baht MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJV, Mohan P, Vinereanu D, Alexander JH. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomsied controlled trial. Lancet 2012;380:1749-58. [Ref.ID 94073]
6.Tiene citas relacionadas
Connolly SJ, Hohnloser SH. Dronedarone in high-risk permanent Atrial fibrillation. Author/editor response. N Engl J Med 2012;366:1161. [Ref.ID 92545]
7.Tiene citas relacionadas Cita con resumen
Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Balleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH, for the ASSERT Investigators. Sublinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-9. [Ref.ID 92210]
8.Tiene citas relacionadas Cita con resumen
Connolly SJ, Camm AJ, Hallperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum A, Blomström P, Borggrefe M, Budaj A, Chen S-A, Ching CK, Commerford P, Dans A, Davy J-M, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH, for the PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011;365:2268-76. [Ref.ID 91613]
9. Cita con resumen
Connolly SJ, Eikelboom J, Joyner C, Diener H-C, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Parkhomenko R, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GYH, Kim JH, Lanas-Zanetti F, González-Hermosillo A, Dans AL, Munawar M, for the AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806-17. [Ref.ID 90023]
10.Tiene citas relacionadas
Hohnloser SH, van Eickels M, Connolly SJ. Dronedarone in atrial fibrillation. The authors reply. N Engl J Med 2009;360:2480-1. [Ref.ID 85990]
11. Cita con resumen
Hohnloser SH, Crijns HJGM, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ, for the ATEHNA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78. [Ref.ID 85242]
12.Tiene citas relacionadas
Singh BN, Hohnloser SH. Dronedarone in atrial fibrillation. The authors reply. N Engl J Med 2007;357:2404. [Ref.ID 81760]
13.Tiene citas relacionadas Cita con resumen
Singh BN, Connolly SJ, Crijns HJGM, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH, for the EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007;357:987-99. [Ref.ID 80958]
14.Tiene citas relacionadas
Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH, for the Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. The OPTIC Study: a randomized trial. JAMA 2006;295:165-71. [Ref.ID 76505]
15. Cita con resumen
Hohnloser SH, Kuck K-H, Lilienthal J, for the PIAF Investigators. Rhythm or rate control in atrial fibrillation - Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94. [Ref.ID 54055]
16.Tiene citas relacionadas Cita con resumen
Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky E N, for the d l-Sotalol Implantable Cardioverter-Defibrillator Study Group. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999;340:1855-62. [Ref.ID 45669]
17.
Hohnloser SH, Woosley RL. Sotalol. N Engl J Med 1994;331:31-8. [Ref.ID 22278]
18. Cita con resumen
Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994;121:529-35. [Ref.ID 22116]
Seleccionar todas
 
 1 a 18 de 18